Inari Gets A Fair Bid As Stryker Buys Yet Another High-Growth Asset
Stryker's acquisition of Inari for $4.9B enhances its neurovascular portfolio and boosts revenue growth by 50bp, with minimal ...
Inari raises $144M as Corteva lawsuit proceeds
Cambridge-based seed design company Inari Agriculture raised one of the first late-stage venture rounds of 2025.
Robert W. Baird Reaffirms “Neutral” Rating for Inari Medical (NASDAQ:NARI)
Inari Medical (NASDAQ:NARI – Get Free Report)‘s stock had its “neutral” rating reaffirmed by Robert W. Baird in a research note issued to investors on Tuesday,Benzinga reports. They presently have a ...
Ag Funder News1d
Seed gene-editing startup Inari eyes commercialization with $144m round: ‘It puts us in a robust financial position’
Seed gene-editing startup Inari has completed a $144 million Series G round, bringing its cumulative funding to $720 million.
Cambridge agtech startup Inari raises equity at $2.17 billion valuation
Massachusetts agtech startup Inari Agriculture Inc. said it raised $144 million of new equity at a $2.17 billion valuation, a ...
5 Things to Know Before the Stock Market Opens
U.S. stock futures are little changed after indexes were mixed Monday; Nvidia stock adds to all-time high after CEO comments; ...
Stryker announces definitive agreement to acquire Inari Medical, Inc., providing entry into high-growth peripheral vascular segment
Stryker (NYSE: SYK), a global leader in medical technologies, announced today a definitive agreement to acquire all of the issued and outstanding shares of common stock of Inari Medical, Inc. (NASDAQ: ...